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Our study of risk factors for T.
gondii infection was a case-control
design to evaluate recent infection,
not a cross-sectional study of T.
gondii infection prevalence in a popu-
lation. In our study, case-patients with
recent infection were similar in age to
T. gondii–negative control-patients,
although among women the mean age
of case-patients (33 years) differed
slightly from that of control-patients
(29 years) (p = 0.03, t-test). In addi-
tion, multivariate analysis comparing
the case-patients with control-patients
showed that age was not a significant
factor. However, when we kept age in
the multivariate model for women (p
= 0.87 for age in the model), the odds
ratio for having had children changed
little, from 14.94 (95% confidence
interval [CI] 3.68–60.73) to 14.01
(95% CI 2.88–68.08). Therefore, we
do think that, in this study population,
having had children is a risk factor for
T. gondii infection among women.
Dr Gomez-Marin also states that
we did not evaluate drinking
water–related factors. However, in
our methods section (1), we indicated
that our questionnaire asked about a
comprehensive set of risk factors
related to drinking water. Specifically,
the questionnaire asked about the
types of water (city, private well, and
others, including bottled water); chlo-
rination; filtering of water; and inges-
tion of water from streams, lakes,
rivers, ponds, or other sources.
Although we evaluated numerous
water-related factors, we did not find
them to be significant in this study,
which applies to 1 area of Brazil. In
other areas of Brazil, however, studies
in which 1 of our authors (J.L.J.) has
been involved have found water to be
a risk factor or a source of infection
(2,3). 
Again, we thank Dr Gomez-
Marin for his letter. We sincerely
appreciate his interest and work with
toxoplasmosis.
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CTX-M Extended-
spectrum 
β β-Lactamases,
Washington State
To the Editor: The CTX-M–type
β-lactamases are non-TEM and non-
SHV plasmid-mediated, class A,
extended-spectrum  β-lactamases
(ESBLs). The CTX-M–type β-lacta-
mases have recently emerged as the
most common type of ESBLs, with a
global distribution (1). In contrast, the
CTX-M–type ESBLs are rarely
reported in the United States and have
not been identified in pathogens iso-
lated from infected patients with
gastroenteritis. 
We screened 637 Salmonella and
126 Shigella isolates, collected in the
state of Washington during
2003–2004, for CTX-M–type β-lacta-
mases. Of these, 60 Salmonella iso-
lates that exhibited an ESBL pheno-
type were further characterized by
PCR for TEV, SHV, CTM-X, and
CMY. All were positive for the CMY-
2 or TEM-1 β-lactam genes. One
Shigella sonnei isolate (WA7593),
cultured from a fecal specimen in
August 2004, tested positive with an
ESBL confirmatory disk diffusion
panel (ceftazidime 24 mm, cef-
tazidime/clavulanate 32 mm, cefo-
taxime 14 mm, and cefotaxime/clavu-
lanate 34 mm; [2]). The patient had
recently traveled to Pakistan and like-
ly became ill there and returned to the
United States while still sick. The
transfer of extended-spectrum
cephalosporin resistance was tested
by conjugation to Escherichia coli
J53 aziR (3). The MIC for S. sonnei
WA7593 and its transconjugant,
WA7593TC1, were tested by using
the E-test (AB Biodisk, Solna,
Sweden). Both strains were resistant
to cefotaxime and susceptible to cef-
tazidime and showed almost the same
antimicrobial susceptibility patterns
as  β-lactam antimicrobial drugs
(Table).
The type of ESBL produced by
these strains was determined by using
PCR specific for TEM and CTX-M
(4,5). Both strains were PCR positive
for TEM and CTX-M. The TEM type
PCR products were then sequenced
and identified as TEM-1; no variation
was found on the promoter region of
blaTEM-1. The entire sequence of
bla CTX-M from WA7593 was then
sequenced (1), and the product
showed 100% homology with
blaCTX-M-15 (GenBank accession no.
AY960984). The mobile element
associated with the transfer of
blaCTX-M-15 was investigated by
sequencing the flanking regions.
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PCRs were performed with primers
from the internal regions of bla CTX-M
gene and primers for insertion
sequences ISEcp1 and IS903 (4,5).
Positive PCR products were obtained
with primers ISEcp1F and CTX2 (943
bp); no amplified product was pro-
duced with primers CTX1 and
IS903R. Sequencing of a 943-bp
amplicon showed that blaCTX-M15 was
flanked upstream by an ISEcp1-like
element. 
The presence of an integron in S.
sonnei WA7593 and WA7593TC1
was investigated by using integron-
specific primers hep35 and hep36 (2).
Only S. sonnei WA7593 produced a
PCR product. This finding suggests
that the transmission of blaCTX-M15 is
not by integron-mediated transfer. A
further 162 Shigella spp. and 260
Salmonella spp. isolated from 2003
through 2005 were also screened for
ESBL production; no further isolates
were identified. 
The presence of a CTX-M–type,
ESBL-producing isolate is rarely
reported in the United States. The
only other reference was from a mul-
tistate study in 2001–2002 that identi-
fied CTX-M type from E. coli isolates
from urine, sputum, and blood (6). No
further reports about CTX-M–produc-
ing organisms have been disseminat-
ed. Our investigation suggests that
CTX-M–type ESBLs may spread
throughout the United States through
infected travelers. This finding is
notable because S. sonnei is a com-
mon enteric pathogen. Our results fur-
ther emphasize that travelers from
others parts of the world can introduce
highly mobile and clinically impor-
tant resistance mechanisms into the
community. The spread of CTX-M
ESBLs may be faster and more wide-
spread than previously thought; there-
fore, CTX-M type should be taken
seriously as a surveillance target in
the United States, especially in
patients with a history of travel out-
side North America.
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HIV and Hepatitis C
Virus Coinfection,
Cameroon
To the Editor: Coinfection with
HIV and hepatitis C virus (HCV) is
now a major public health concern
worldwide, owing both to its high
prevalence (4–5 million persons of 40
million infected by HIV) and to inter-
actions between the 2 diseases in
terms of their diagnosis, natural
course, and treatment (1,2). Although
Africa is the continent by far the most
badly affected by both HIV and HCV
infections, data on coinfection in the
general population are lacking. In
Cameroon, a central African country,
the HCV seroprevalence is among the
highest in the world (13.8%) (3). We
have also reported a high seropreva-
lence of HIV in a general population
of southern Cameroon (7.4%), and
especially in young women (22.5%)
(4). Here, we investigated the preva-
lence of HIV/HCV coinfection in this
population.
A population-based, cross-sec-
tional survey was conducted in
September 2001 in 3 villages of the
East Province of Cameroon (250 km
from Yaoundé, the capital city). The
study methods, the baseline character-
istics of the participants, and the HIV